current standards and future prospects for the treatment of hormone refractory prostate cancer
Published 1 year ago • 215 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
2:10
current standards for first-line metastatic hormone-sensitive prostate cancer
-
1:41
future developments in the treatment of prostate cancer
-
1:34
combination therapies for the treatment of prostate cancer
-
3:44
the evolving standard of care for patients with metastatic hormone-sensitive prostate cancer
-
11:26
the future of radiotherapy for prostate cancer
-
3:13
prostate cancer: treatment sequencing and choice
-
6:53
perspectives on metastatic hormone-sensitive prostate cancer | bayer
-
5:06
va starport prostate cancer clinical trial
-
1:15
exciting times for hormone-sensitive prostate cancer treatment
-
7:32
a new approach to prostate cancer treatment?
-
8:44
finding an oncologist for advanced disease | scanning for metastases early | mark scholz, md | pcri
-
1:17
abiraterone for the treatment of cn1 prostate cancer
-
1:35
parp inhibitors for the treatment of metastic castration-resistant prostate cancer
-
1:49
radioligands in the future of prostate cancer treatment
-
1:23
the evolving treatment landscape of mhspc and mcrpc
-
2:41
recent developments in treatment options for castration-sensitive metastatic prostate cancer
-
1:17
treatment landscape for metastatic hormone-sensitive prostate cancer
-
3:29
assessing intermediate clinical endpoints as potential surrogates for os in prostate cancer
-
5:37
combination therapy for the teal stage of prostate cancer | prostate cancer staging guide